VANDA PHARMACEUTICALS INC
VNDANASDAQ🏆 #3059 by market capEarnings Nov 4US Equity
$5.15▲ $0.22 (+4.36%)
Live1h▲ 1.3%
24h▲ 4.4%
7d▲ 2.1%
14d▲ 1.9%
30d▼ 14.0%
1y▲ 19.4%
🏦Market Cap
$309M
Small Cap
📈Revenue Growth (YoY)
+8.2%
Slowing
📊Gross Margin
94.2%
High
💵FCF Margin
3.5%
Moderate
⚖️P/S Ratio
1.3x
Cheap
Otter Score
55
Weak
Earnings
Q3 · 2026Reported 2026-08-05Earnings Per Share
Actual
-1.04
Expected
-0.58
miss
−78.50%
YoY −126.10%
Revenue
Actual
$50.53M
Expected
$61.92M
miss
−18.40%
YoY −3.90%
Consensus estimates
Recent quarters
Q3 2026
-1.04
miss
Q2 2026
-0.82
miss
Q1 2026
-0.46
beat
Q4 2025
-0.38
miss